Genospectra has secured the rights to intellectual property held by The Scripps Research Institute for state-responsive dyes for live-cell biosensing and monitoring protein-protein interactions, the company said last week.

With the IP acquisition, Genospectra adds another item to its molecular biology toolbox, which the company calls “Parallel Quantitative Biology.” Thus far, this initiative has focused primarily on nucleic-acid based applications, such as the company’s QuantiGene platform for gene-expression profiling in fresh cell lysates.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.